Midazolam Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 04/02/2020.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-2596-03
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)
- Initial Posting
- 04/02/2020
- Revised Date